Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer: Early assessment predicts clinical response

Clinical Cancer Research

Volumn 9, Issue 3, 2003, Pages 955-960

  Davis, Darren W ^a   Buchholz, Thomas A ^a   Hess, Kenneth R ^a   Sahin, Aysegul A ^a   Valero, Vincente ^a   McConkey, David J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DNA FRAGMENT; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL;

APOPTOSIS; ARTICLE; AUTOMATION; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMETRY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR CELL; TUMOR XENOGRAFT;

APOPTOSIS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DNA FRAGMENTATION; DOXORUBICIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; NEOPLASM TRANSPLANTATION; PACLITAXEL; TAXOIDS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0037339961     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Hengartner, M. O. The biochemistry of apoptosis. Nature (Lond.), 407: 770-776, 2000.
2. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Wash. DC), 267: 1456-1462, 1995.
3. Eastman, A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells (Cold Spring Harbor), 2: 275-280, 1990.
4. Johnstone, R. W., Ruefli, A. A., and Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell, 108: 153-164, 2002.
5. Davis, D. W., Weidner, D. A., Holian, A., and McConkey, D. J. Nitric oxide-dependent activation of p53 suppresses bleomycin-induced apoptosis in the lung, J. Exp. Med., 192: 857-869, 2000.
6. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
7. McCloskey, D. E., Kaufmann, S. H., Prestigiacomo, L. J., and Davidson, N. E. Paclitaxel induces programmed cell death in MDAMB-468 human breast cancer cells. Clin. Cancer Res., 2: 847-854, 1996.
8. Nawrocki, S. T., Bruns, C. J., Harbison, M. T., Bold, R. J., Gotsch, B. S., Abbruzzese, J. L., Elliott, P., Adams, J., and McConkey, D. J. Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts. Mol. Cancer Ther., 1: 1243-1253, 2002.
9. Savill, J., and Fadok, V. Corpse clearance defines the meaning of cell death, Nature (Lond.), 407: 784-788, 2000.
10. Chang, J., Ormerod, M., Powles, T. J., Allred, D. C., Ashley, S. E., and Dowsett, M. Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer (Phila.), 89: 2145-2152, 2000.
11. Symmans, W. F., Volm, M. D., Shapiro, R. L., Perkins, A. B., Kim, A. Y., Demaria, S., Yee, H. T., McMullen, H., Oratz, R., Klein, P., Formenti, S. C., and Muggia, F. Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment. Clin. Cancer Res., 6: 4610-4617, 2000.
12. Symmans, F. W. Breast cancer response to paclitaxel in vivo, Drug Resist Updat., 4: 297-302, 2001.
13. Green, A. M., and Steinmetz, N. D. Monitoring apoptosis in real time. Cancer J., 8: 82-92, 2002.